Quanterix
Quanterix Restructuring Efforts on Track, CEO Says at JP Morgan Conference
The restructuring is to scale its operations and assays to better meet both current and anticipated demand for higher-throughput testing, its CEO said.
Rapid Antigen Tests Effective for SARS-CoV-2 Variants, Study Finds
An Emory University-led team examined the effects of mutations in the SARS-CoV-2 nucleocapsid protein on existing antigen tests.
Canaccord Downgrades Quanterix From Buy to Hold
The bank slashed its price target from $40 to $12, noting that the change was driven by a lack of near-term visibility and catalysts that would increase its valuation.
The firm, which reported a 7 percent drop in Q2 revenues, is laying off roughly 130 workers as it focuses on improving assay quality and scaling its manufacturing.
A Science report highlighting potential fraud in an Alzheimer's paper could undermine therapeutic efforts but has little implication for the utility of tests for the disease.